Sumitomo Mitsui Trust Holdings Inc. Acquires 153,400 Shares of athenahealth, Inc. (ATHN)
Sumitomo Mitsui Trust Holdings Inc. raised its holdings in athenahealth, Inc. (NASDAQ:ATHN) by 124.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 276,700 shares of the health services provider’s stock after purchasing an additional 153,400 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 0.69% of athenahealth worth $34,410,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Turner Investments LLC purchased a new stake in shares of athenahealth in the second quarter valued at about $105,000. Bessemer Group Inc. raised its position in shares of athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares during the last quarter. Seven Bridges Advisors LLC increased its position in athenahealth by 5.4% during the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after purchasing an additional 67 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its position in athenahealth by 123.8% during the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares during the last quarter.
athenahealth, Inc. (ATHN) opened at $130.23 on Thursday. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth, Inc. has a 52 week low of $90.11 and a 52 week high of $158.66. The company has a market cap of $5,224.71, a price-to-earnings ratio of 110.64, a price-to-earnings-growth ratio of 5.19 and a beta of 1.57.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. During the same period last year, the firm posted $0.60 EPS. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. equities research analysts predict that athenahealth, Inc. will post 1.13 earnings per share for the current fiscal year.
In other news, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $130.38, for a total value of $39,114.00. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,283 shares of company stock worth $1,741,372. Insiders own 3.20% of the company’s stock.
Several brokerages recently commented on ATHN. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $170.00 price target (up previously from $150.00) on shares of athenahealth in a research report on Wednesday, August 2nd. Cowen and Company lowered shares of athenahealth from an “outperform” rating to a “market perform” rating and upped their price target for the stock from $127.00 to $133.00 in a research report on Monday, July 31st. Morgan Stanley reaffirmed an “equal weight” rating and set a $125.00 price target (up previously from $108.00) on shares of athenahealth in a research report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $184.00 price target on shares of athenahealth in a research report on Friday, October 20th. Finally, BidaskClub lowered shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $143.22.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.